Testing Monotonicity in a Finite Population
有限总体中的单调性检验AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要直接研究随机实验中个体处理效应及其同号限制的可检验性。
有限总体中的单调性检验AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
We consider the extent to which we can learn from a completely randomized experiment whether all individuals have treatment effects that are weakly of the same sign, a condition we call monotonicity. From a classical sampling perspective, it is well-known that monotonicity is not falsifiable. We show that from the design-based perspective---in which the potential outcomes are fixed and only treatment assignment is stochastic---that the distribution of treatment effects in the finite population (and hence whether monotonicity holds) is formally identified. Nevertheless, we show that the scope for learning about violations of monotonicity is severely limited. Frequentist tests of monotonicity have generically poor power, and there exist (non-degenerate) Bayesian priors that never update about whether monotonicity holds. Estimators of the magnitude of the violation of monotonicity are likewise shown to have poor minimax mean-squared error.
潜在类别对处理效应的调节
Many treatments have effects that plausibly vary by latent classes. For example, the effect of personalized video recommendations may be stronger for users who seek a new discovery than for users seeking to rewatch something familiar. In the context of user journeys on digital platforms, we can conceptualize user moods as dynamic latent states that lead to distinct action distributions. Because mood is unobserved, we infer it from a user's pre-treatment actions using a…
处理是否有益?有序结局因果推断的贝叶斯方法
Randomized experiments with ordinal outcomes are common across scientific applications, but conventional causal estimands such as the average treatment effect are difficult to interpret because ordinal categories lack meaningful numerical spacing. Two interpretable estimands, the probabilities that the treatment is beneficial and strictly beneficial, depend on the joint distribution of the potential outcomes and are therefore not identifiable from observed data. The sharp…
BGM-IV:面向高维协变量工具变量回归的贝叶斯生成建模
Instrumental-variable (IV) regression enables causal estimation under endogeneity, but modern IV problems often involve nonlinear structural effects and high-dimensional covariates. Existing methods typically operate in observed or generic learned feature spaces, and they often yield point estimates without uncertainty quantification. We introduce BGM-IV, a Bayesian generative modeling approach that performs nonlinear IV regression through posterior inference in a causally…
析因多变量贝叶斯因果森林:多处理的异质主效应与交互效应
Many studies expose units to several binary treatments at once and record several correlated outcomes, yet analysts usually estimate one treatment's average effect on one outcome at a time -- discarding how treatments interact and how their effects vary across units. We introduce the factorial multivariate Bayesian causal forest, a Bayesian nonparametric model that decomposes the factorial response surface over the treatment lattice into a prognostic sum-of-trees plus one…
基于贝叶斯机器学习的决策论亚组发现
We consider the problem of identifying promising subpopulations in terms of treatment effectiveness or treatment effect heterogeneity, from a Bayesian decision theoretic perspective. We first show that a straight-forward application of Bayesian decision theory to subgroup detection leads to a counter-intuitive risk-seeking (RS) behavior. Motivated by this observation, we introduce the Bayesian Risk-Aware Inference and Detection of Subgroups (BRAIDS) utility and use it to…
伪增量检验:利用自然发生的干预衡量广告增量效应
We develop a method for measuring the incremental effect of advertising when randomized exper- iments are unavailable. Firms generate abrupt interventions in their own marketing as a byproduct of operations: budgets are cut, channels launch, programs pause. We propose a two-stage proce- dure that treats these events as quasi-experiments. The first stage discovers and dates interventions by exact Bayesian run-length inference on marketing activity series. The second stage…